Is percutaneous coronary angioplasty less expensive than bypass surgery?

G. S. Reeder, I. Krishan, F. T. Nobrega, James M Naessens, M. Kelly, J. B. Christianson, M. K. McAfee

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Percutaneous transluminal coronary angioplasty is widely considered to be an acceptable and less expensive alternative to bypass surgery in carefully selected patients. We compared expenditures related to cardiac care for 79 unselected patients undergoing coronary angioplasty with expenditures for 89 unselected patients undergoing elective coronary bypass surgery without a previous attempt at angioplasty. All the patients had single-vessel disease. The mean aggregate one-year monetary outlay was 15 per cent lower in the angioplasty group than in the bypass-surgery group. A major component of the expense of angioplasty was the treatment of restenosis in the 33 per cent of patients in this group in whom this late complication occurred. We conclude that percutaneous transluminal coronary angioplasty has potential for reducing expenditures for cardiac revascularization and that a further reduction may be obtainable when the rates of restenosis are improved.

Original languageEnglish (US)
Pages (from-to)1157-1162
Number of pages6
JournalNew England Journal of Medicine
Volume311
Issue number18
StatePublished - 1984

Fingerprint

Angioplasty
Health Expenditures
Coronary Balloon Angioplasty
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Reeder, G. S., Krishan, I., Nobrega, F. T., Naessens, J. M., Kelly, M., Christianson, J. B., & McAfee, M. K. (1984). Is percutaneous coronary angioplasty less expensive than bypass surgery? New England Journal of Medicine, 311(18), 1157-1162.

Is percutaneous coronary angioplasty less expensive than bypass surgery? / Reeder, G. S.; Krishan, I.; Nobrega, F. T.; Naessens, James M; Kelly, M.; Christianson, J. B.; McAfee, M. K.

In: New England Journal of Medicine, Vol. 311, No. 18, 1984, p. 1157-1162.

Research output: Contribution to journalArticle

Reeder, GS, Krishan, I, Nobrega, FT, Naessens, JM, Kelly, M, Christianson, JB & McAfee, MK 1984, 'Is percutaneous coronary angioplasty less expensive than bypass surgery?', New England Journal of Medicine, vol. 311, no. 18, pp. 1157-1162.
Reeder GS, Krishan I, Nobrega FT, Naessens JM, Kelly M, Christianson JB et al. Is percutaneous coronary angioplasty less expensive than bypass surgery? New England Journal of Medicine. 1984;311(18):1157-1162.
Reeder, G. S. ; Krishan, I. ; Nobrega, F. T. ; Naessens, James M ; Kelly, M. ; Christianson, J. B. ; McAfee, M. K. / Is percutaneous coronary angioplasty less expensive than bypass surgery?. In: New England Journal of Medicine. 1984 ; Vol. 311, No. 18. pp. 1157-1162.
@article{279c51383a054859bf5ebdec2ac2aa2b,
title = "Is percutaneous coronary angioplasty less expensive than bypass surgery?",
abstract = "Percutaneous transluminal coronary angioplasty is widely considered to be an acceptable and less expensive alternative to bypass surgery in carefully selected patients. We compared expenditures related to cardiac care for 79 unselected patients undergoing coronary angioplasty with expenditures for 89 unselected patients undergoing elective coronary bypass surgery without a previous attempt at angioplasty. All the patients had single-vessel disease. The mean aggregate one-year monetary outlay was 15 per cent lower in the angioplasty group than in the bypass-surgery group. A major component of the expense of angioplasty was the treatment of restenosis in the 33 per cent of patients in this group in whom this late complication occurred. We conclude that percutaneous transluminal coronary angioplasty has potential for reducing expenditures for cardiac revascularization and that a further reduction may be obtainable when the rates of restenosis are improved.",
author = "Reeder, {G. S.} and I. Krishan and Nobrega, {F. T.} and Naessens, {James M} and M. Kelly and Christianson, {J. B.} and McAfee, {M. K.}",
year = "1984",
language = "English (US)",
volume = "311",
pages = "1157--1162",
journal = "New England Journal of Medicine",
issn = "1533-4406",
publisher = "Massachussetts Medical Society",
number = "18",

}

TY - JOUR

T1 - Is percutaneous coronary angioplasty less expensive than bypass surgery?

AU - Reeder, G. S.

AU - Krishan, I.

AU - Nobrega, F. T.

AU - Naessens, James M

AU - Kelly, M.

AU - Christianson, J. B.

AU - McAfee, M. K.

PY - 1984

Y1 - 1984

N2 - Percutaneous transluminal coronary angioplasty is widely considered to be an acceptable and less expensive alternative to bypass surgery in carefully selected patients. We compared expenditures related to cardiac care for 79 unselected patients undergoing coronary angioplasty with expenditures for 89 unselected patients undergoing elective coronary bypass surgery without a previous attempt at angioplasty. All the patients had single-vessel disease. The mean aggregate one-year monetary outlay was 15 per cent lower in the angioplasty group than in the bypass-surgery group. A major component of the expense of angioplasty was the treatment of restenosis in the 33 per cent of patients in this group in whom this late complication occurred. We conclude that percutaneous transluminal coronary angioplasty has potential for reducing expenditures for cardiac revascularization and that a further reduction may be obtainable when the rates of restenosis are improved.

AB - Percutaneous transluminal coronary angioplasty is widely considered to be an acceptable and less expensive alternative to bypass surgery in carefully selected patients. We compared expenditures related to cardiac care for 79 unselected patients undergoing coronary angioplasty with expenditures for 89 unselected patients undergoing elective coronary bypass surgery without a previous attempt at angioplasty. All the patients had single-vessel disease. The mean aggregate one-year monetary outlay was 15 per cent lower in the angioplasty group than in the bypass-surgery group. A major component of the expense of angioplasty was the treatment of restenosis in the 33 per cent of patients in this group in whom this late complication occurred. We conclude that percutaneous transluminal coronary angioplasty has potential for reducing expenditures for cardiac revascularization and that a further reduction may be obtainable when the rates of restenosis are improved.

UR - http://www.scopus.com/inward/record.url?scp=0021162404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021162404&partnerID=8YFLogxK

M3 - Article

VL - 311

SP - 1157

EP - 1162

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 1533-4406

IS - 18

ER -